These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 35751779

  • 1. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M, Mínguez Ojeda C, Sánchez Ramírez MN, Gómez Dos Santos V, Pascual-Corrrales E, Fernández-Argüeso M.
    Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
    [Abstract] [Full Text] [Related]

  • 2. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M.
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
    Brox-Torrecilla N, García Cano AM, Valderrábano P, Quintero Tobar A, Escobar-Morreale HF, Araujo-Castro M.
    Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
    [Abstract] [Full Text] [Related]

  • 6. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A, Janez A, Goricar K, Jensterle M.
    BMC Endocr Disord; 2020 Jul 31; 20(1):118. PubMed ID: 32736549
    [Abstract] [Full Text] [Related]

  • 7. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Leão ATT, Vieira Neto L.
    J Endocrinol Invest; 2021 Nov 31; 44(11):2455-2463. PubMed ID: 33788166
    [Abstract] [Full Text] [Related]

  • 8. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M, Hanzu FA, Pascual-Corrales E, García Cano AM, Marchan M, Escobar-Morreale HF, Valderrabano P, Casals G.
    Endocrine; 2023 Oct 31; 82(1):161-170. PubMed ID: 37351760
    [Abstract] [Full Text] [Related]

  • 9. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
    Arruda M, Mello Ribeiro Cavalari E, Pessoa de Paula M, Fernandes Cordeiro de Morais F, Furtado Bilro G, Alves Coelho MC, de Oliveira E Silva de Morais NA, Choeri D, Moraes A, Vieira Neto L.
    J Hum Hypertens; 2017 Dec 31; 32(1):3-11. PubMed ID: 29176595
    [Abstract] [Full Text] [Related]

  • 10. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
    Araujo-Castro M, Pascual-Corrales E, Lamas C.
    Ann Endocrinol (Paris); 2023 Apr 31; 84(2):272-284. PubMed ID: 36736771
    [Abstract] [Full Text] [Related]

  • 11. Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.
    Kim JH, Kim MJ, Lee JH, Yoon JW, Shin CS.
    Endocr Pract; 2020 Dec 31; 26(12):1406-1415. PubMed ID: 33471732
    [Abstract] [Full Text] [Related]

  • 12. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
    Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G.
    Clin Endocrinol (Oxf); 2017 Apr 31; 86(4):488-498. PubMed ID: 27992961
    [Abstract] [Full Text] [Related]

  • 13. Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients With Adrenal Incidentaloma.
    Moraes AB, de Paula MP, de Paula Paranhos-Neto F, Cavalari EMR, de Morais FFC, Curi DSC, Lima LFC, de Mendonça LMC, Farias MLF, Madeira M, Vieira Neto L.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32413110
    [Abstract] [Full Text] [Related]

  • 14. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T.
    Front Endocrinol (Lausanne); 2023 Aug 01; 14():1123132. PubMed ID: 37223045
    [Abstract] [Full Text] [Related]

  • 15. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP.
    J Clin Endocrinol Metab; 2014 Aug 01; 99(8):2754-62. PubMed ID: 24712565
    [Abstract] [Full Text] [Related]

  • 16. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P, Orsolini F, Benelli E, Agretti P, Vitti P, Di Cosmo C, Tonacchera M.
    Endocrine; 2021 Jan 01; 71(1):178-188. PubMed ID: 32915435
    [Abstract] [Full Text] [Related]

  • 17. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
    Araujo-Castro M, Casals G, Hanzu FA, Pascual-Corrales E, García Cano AM, Lanza VF, Luis Del Rey Mejías Á, Marchan M, Escobar-Morreale HF, Valderrabano P.
    Clin Endocrinol (Oxf); 2023 Feb 01; 98(2):165-176. PubMed ID: 35973974
    [Abstract] [Full Text] [Related]

  • 18. Diabetes Mellitus in Non-Functioning Adrenal Incidentalomas: Analysis of the Mild Autonomous Cortisol Secretion (MACS) Impact on Glucose Profile.
    Trandafir AI, Ghemigian A, Ciobica ML, Nistor C, Gurzun MM, Nistor TVI, Petrova E, Carsote M.
    Biomedicines; 2024 Jul 18; 12(7):. PubMed ID: 39062179
    [Abstract] [Full Text] [Related]

  • 19. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr 18; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P.
    Hormones (Athens); 2021 Dec 18; 20(4):735-744. PubMed ID: 34273083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.